期刊
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA
卷 14, 期 5, 页码 E161-E163出版社
CIG MEDIA GROUP, LP
DOI: 10.1016/j.clml.2014.06.004
关键词
Mitogen-activated protein kinase; Mutation; Refractory myeloma; Vemurafenib; V600E